Dr. Samir Saba, MD
Claim this profileUPMC Heart and Vascular Institute
Affiliated Hospitals
UPMC Heart And Vascular Institute
University Of Pittsburgh Medical Center
Clinical Trials Samir Saba, MD is currently running
ICM Implantation
for Heart Attack
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
Recruiting
1 award
N/A
5 criteria
Left Atrial Appendage Occlusion vs. NOAC
for Atrial Fibrillation
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Recruiting
1 award
N/A
8 criteria
More about Samir Saba, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Samir Saba, MD has experience with
- ICM Implantation
- Atrial Fibrillation Education
- WiSE System
- Amplatzer Amulet LAA Occluder
- Non-Vitamin K Oral Antagonists
Breakdown of trials Samir Saba, MD has run
Atrial Fibrillation
Heart Attack
Heart Failure
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samir Saba, MD specialize in?
Samir Saba, MD focuses on Atrial Fibrillation and Heart Attack. In particular, much of their work with Atrial Fibrillation has involved treating patients, or patients who are undergoing treatment.
Is Samir Saba, MD currently recruiting for clinical trials?
Yes, Samir Saba, MD is currently recruiting for 2 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Samir Saba, MD has studied deeply?
Yes, Samir Saba, MD has studied treatments such as ICM Implantation, Atrial Fibrillation Education, WiSE System.
What is the best way to schedule an appointment with Samir Saba, MD?
Apply for one of the trials that Samir Saba, MD is conducting.
What is the office address of Samir Saba, MD?
The office of Samir Saba, MD is located at: UPMC Heart and Vascular Institute, Pittsburgh, Pennsylvania 15213 United States. This is the address for their practice at the UPMC Heart and Vascular Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.